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Abstract
Summary The study rationale was to provide a detailed over-
view of the costs, quality of life and mortality of hip fractures
in Portugal. Mean individual fracture-related costs were esti-
mated at €13,434 [12,290; 14,576] for the first year and €5985
[4982; 7045] for the second year following the fracture.
Introduction Osteoporotic fractures represent a remarkable
burden to health care systems and societies worldwide, which
will tend to increase as life expectancy expands and lifestyle
changes favour osteoporosis. The cost-effectiveness evalua-
tion of intervention strategies demands accurate data on the
epidemiological and economical reality to be addressed.
Methods Information was collected retrospectively on con-
sumption of resources and changes in quality of life attribut-
able to fracture as well as mortality, regarding 186 patients
randomly selected to represent the distribution of hip fractures
in the Portuguese population, in terms of gender, age and
geographical provenience. Data were cross-tabulated with
socio-demographic variables and individual resource con-
sumption to estimate the burden of disease. A societal per-
spective was adopted, including direct and indirect costs.
Multivariate analyses were carried out to assess the main de-
terminants of health-related quality of life (HrQoL).
Results Mean individual fracture-related costs were estimated
at €13,434 [12,290; 14,576] for the first year and €5985
[4982; 7045] for the second year following the fracture. In
2011 the economic burden attributable to osteoporotic hip
fractures in Portugal could be estimated at €216 million.
Mean reduction in HrQoL 12 months after fracture was esti-
mated at 0.34. Regression analysis showed that age was asso-
ciated with a higher loss of HrQoL, whereas education had the
opposing effect. We observed 12 % excess mortality in the
first year after hip fracture, when compared to the gender and
age-matched general population.
Conclusions Results of this study indicate that osteoporotic
hip fractures are, also in Portugal, despite its low incidence
of fractures and cost per event, associated with a high societal
burden, in terms of costs, loss in HrQoL and mortality. These
data provide valuable input to the design and selection of
fracture prevention strategies.
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Introduction
Osteoporotic fractures impact an enormous burden upon so-
cieties due to costs related to immediate treatment and also to
the management of their long-term consequences in terms of
disability, comorbidity and mortality.
It has been estimated that the annual number of osteopo-
rotic fractures in the European Unionwill rise from 3.5million
in 2010 to 4.5 million in 2025, corresponding to an increase of
28 % [1]. The annual worldwide direct and indirect costs of
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hip fractures have been calculated at $34.8 billion in 1990 and
are expected to rise to an estimated $131 billion by 2050 [2].
This burden and its prospected increase impose the need
for careful evaluation of the cost-effectiveness of different
intervention strategies. These strategies need to be adapted
to the actual epidemiological and economical reality that they
intend to address, as it can be quite diverse [3]. Portugal has a
relatively low incidence of osteoporotic hip fractures at
around 206 cases per 100,000 population aged 40+ [4]. The
management of osteoporotic fractures, as well as the cost of
treatment, can also vary [5].
Hip fractures are a useful surrogate for determining the
overall burden of osteoporosis, as they are more readily iden-
tified in hospital discharge registers. Studies performed in
countries with reliable registers of all types of fractures are
typically used to extrapolate from data obtained with hip frac-
tures [1]. However, detailed cost-of-illness (COI) studies re-
garding hip fractures must be performed in each country if
locally valid guidance and conclusions are to be drawn.
To the extent of our knowledge, this is the first study to
estimate the overall societal cost of hip fractures, the per-
patient costs and the impact on heath-related quality of life
in Portugal, based on real-life individual patient data.
Methods and material
In this study, we adopt a prevalence-based approach time [6].
We took a societal perspective in the measurement of costs [6].
Data on resource consumption over the 2 years following the
fracture were collected retrospectively regarding fractures that
occurred 24 to 30 months before the interview. Patients them-
selves or their primary caregivers provided the information.
By ‘primary caregiver’, we mean the person responsible for
managing the care of the patient, i.e. the family member or
trained professional who took care of medication, personal
support and medical appointments throughout the 2 years of
interest. If such a person could not be clearly identified, the
patient was excluded and another one recruited.
A draft version of the questionnaire was tested in ten indi-
viduals and adaptive corrections were introduced into the final
version, as recommended [7, 8]. The first part of the question-
naire covered patient socio-demographic data and the quanti-
ties of resources consumed over the 2-year period following
fracture or until death. The second part of the questionnaire
aimed to assess the patients’ health-related quality of life
(HrQoL). We used the EQ-5D instrument in the version vali-
dated for the Portuguese population that contain a Portuguese
tariff [9]. These questions were focused onto three different
moments: (1) before the hip fracture, (2) 1 month after the
fracture and (3) 1 year after the fracture. The interviews were
conducted by telephone by three trained interviewers (AM;
IL; JS) and took, on average, 25 min. Participants were asked
to identify solely expenses incurred as a consequence of frac-
ture and none other.
The resources consumed by patients were categorised into
direct medical costs (inpatient care, rehabilitation care, outpa-
tient consultations, osteoporosis preventive medications, diag-
nostic tests and nursing care) and direct non-medical costs
(long-term care, nursing home, patient’s transportation, tech-
nical aids, home adaptations, home care, informal care and
burial) as performed by several authors [3, 7, 10, 11]. Costs
associated with productivity changes due to the hip fracture
were also included in the analysis [12]. Information regarding
the definition of resources and their unit cost is provided in
Supplementary Material (Table 1).
Participation was explicitly voluntary and ethical approval
was obtained from the Ethical Committee of the Faculty of
Medicine of Coimbra University.
Power calculations
In the calculations for the sample size, performed to establish
the minimum number of patients required to ensure reliability
of the national estimates of the mean cost per fracture, we
decided to assume a range of total costs between €25001 and
€20,0002 for the first year, thus deriving an estimate of the SD
of about 4375.3 Establishing an absolute maximum error of
estimation on €800,4 not to be exceeded with higher than 5 %
probability, the sample size required is 114 units.5 Due to the
uncertainty in the population’s SD estimate, we planned to
include 186 patients (details on the statistical calculations
employed can be found on references [13, 14].
Patient selection
We obtained demographic information about all osteoporotic
hip fractures treated in Portuguese public hospitals in the year
2011, through the National Hospital Discharge Register.
Public hospitals are estimated to take care of over 95 % of
all osteoporotic hip fractures in Portugal. Based on the ob-
served cases, we designed a stratified random sampling meth-
od—the size of the sample in each stratum was proportionate
to the size of the stratum in the population. We defined the
1 €2500 corresponds to the comprehensive cost of inpatient care
to treat a hip fracture. Table 1 shows the source of this figure.
2 €20,000 corresponds approximately to the upper 95 % con-
fidence interval for Sweden [7], assuming the replacement
costing method.
3 [13] refers that and estimate of the SD can be found by
computing the range divided by 4.
4 € 800 is approximately equivalent to 5 % of the mean cost of
hip fracture in Sweden [7] assuming the replacement cost method
5 The sample size estimation accounted for fact that we are
extracting a random sample from a finite population.
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following strata: geographical origin, gender and the age
groups ≤74, 75 to 85, and ≥85 years. Twenty-six hospitals in
Portugal mainland were selected and invited to collaborate in
the study. Each hospital was requested to recruit a number of
cases per strata proportionally equivalent to its representation
in the national hip fracture case list 2011.
A representative from each hospital, typically the head of
the orthopaedics department, was asked to provide the contact
of a pre-defined number of consenting patients of specific
age×gender combination. These participants were randomly
selected from within the full list of hip fracture victims locally
treated in 2011, following a web-based random number gen-
erator. There were no exclusion criteria. Even patients who
had died or were unable to answer were included if the prima-
ry caregiver remains the same over all the period of study. To
decrease the likelihood of refusals and respect the principles
underlying the ethical approval, the local hospital representa-
tive contacted directly the patient or caregiver, presented the
goals of the project and asked for permission (consent) for a
subsequent phone enquiry by the research team. In total, 212
individuals were selected according to these criteria. Twenty-
six were excluded because of difficulties in contact (n=13),
refusal (n=9) and unavailability or undefinition of primary
caregiver (n=4). We confirmed that five of these twenty-six
patients had died since the fracture.
Statistical analysis
Information is summarized as arithmetic means with 95 % con-
fidence intervals (CIs) or percentages as appropriate. When
informative, we also display the standard deviation of some
statistics. Student’s t tests were conducted to compare means
and two-proportion z test was adopted compare proportions.
The expected number of deaths in our sample was estimat-
ed on the basis of national gender and age-specific mortality
rates. Our data contain the number of days until death after the
hip fracture, we use these data to estimate the survival, and to
compare across groups, we use the log-rank test [15].
A multiple linear regression model was used to analyse the
relationship between HrQoL and a set of potentially relevant
independent variables. Further information regarding the defi-
nition of all variables and the methodology used in the regres-
sion models can be found in the BSupplementaryMaterial^. All
statistical analyses were conducted using Stata, version 12.0.
Results
We collected data from 186 patients. Demographic characteris-
tics of participants are presented in Table 1.Mean age at fracture
was 80.5 years and 78.5 % of the respondents were female.
These data, as well as the geographical distribution, correspond
almost perfectly to the parameters of the total population that
suffered hip fractures in Portugal over the year 2011 (total N=
11,124, mean age 80.5±9.9 years and 76 % female, differences
not statistically significant). On average, these patients had
attended school for 3.5 years (SD 2.82). Prior to fracture,
85.5 % resided on their own house, 10.2 % lived with relatives,
and 4.3 % already resided in a nursing home.
Resource use and costs
Table 2 presents the proportion of patients who used each type
of resource as a consequence of the hip fracture. The likeli-
hood of utilization of each type of resource is much higher
during the first year following the facture than in the second
year. Further to hospital admission, nearly 100 % visited a
physician at least once and used diagnostic tests. Technical
aids were purchased by 85 % of patients, transportation by
ambulance was used by75.8 %, and 61.8 % received rehabil-
itation care. Only 29.6 % were treated with calcium and/or
vitamin D, and 16.7 % received other anti-osteoporotic agents
within the 2 years following the fracture. After discharge from
hospital, 18.3% of the patients were transferred to a long-term
care facility and 19.9 %to a nursing home; 18.3 % of the
patients needed home care support and 32.3 % receive
care from a nurse. During the second year, there was
a marked decrease of the variety and quantity of re-
sources used: no consumption of nursing care, technical
aids, diagnostic tests and transportation were reported as
due to the hip fracture in the second year. Regarding
family and friends’ support, 62.9 % of patients reported
receiving an average of 32.9 h by week of this type of care,
as a consequence of the fracture, during the first year.
Productivity losses were only reported by four patients—all
the remaining participants were already retired.
Table 1 Summary of patient demographics
Total 186 (=100 %)
Gender, N (%) Female 146 (78.5)
Male 40 (21.5)
Age, N (%) ≤74 36 (19.4)
≥75<85 92 (49.4)
≥85 58 (31.2)




Residence prior to fracture Own house 159 (85.5)
With relatives 19 (10.2)
Nursing home 8 (4.3)




Table 3 presents an estimate of the cost (€), per patient and
per year, for each type of resource considered, stratified by
gender. Considering all resources, the average cost per patient,
per year, for treating a hip fracture in Portugal is estimated at
€13,434 for the first year and in €5985 for the second year
after the hip fracture. With reference to the first year, 28 % of
the total costs are due to direct medical costs, 70 % due to
direct non-medical costs and the remaining 2 % are indirect
costs due to productivity losses. During the second year, there
is a marked decrease of costs, the most relevant item being
informal care (€3549). Participants did not report any costs
associated with transportation or technical aids in the second
year. The productivity loss cost category was only verified in
four men and contributed an average of €194 for the total cost
of each hip fracture.
We verified that variable type of respondent (caregiver/pa-
tient) does not have a significant influence upon costs or qual-
ity of life in the multivariate regression analysis. Data are not
shown.
Taking into account the 11,124 hip fractures that occurred
in year 2011 in mainland Portugal, the total societal cost for
the first year of treatment was estimated at €149 million.
Direct medical costs, direct non-medical costs and indirect
costs represent approximately 28.4, 70.2 and 1.4 % of this
value, respectively. This total value must be added to €66
Table 2 Patients making use of specific resources, due to hip fracture,
by year of consumption: percentage (n)
Resource Year 1 (n=186) Year 2 (n=148)
Rehabilitation care 61.8 (115) 8.06 (12)
Inpatient care 100 (186) 2.15 (3)
Medical consultations 97.3 (181) 45.9 (70)
Osteoporosis treatment 16.7 (31) 16.7 (25)




Nursing care 32.3 (60) 0
Long-term care 18.3 (34) 0.5 (1)
Nursing home 19.9 (37) 15.5 (23)
Home care 18.3 (34) 14.5 (21)
Technical aids 85 (158) 0
Transportation 75.8 (141) 0
Informal care 62.9 (117) 41.4 (61)
Productivity losses 2.15 (4) 0
Table 3 Costs in euros, per patient and per year, for each type of resource considered
Year 1 Year 2 Year 1 female Year 1 male Year 2 female Year 2 male
Direct medical costs
Rehabilitation care 1056 [845; 1266] 179 [73; 285] 1040 [799; 1281] 1115 [666; 1563] 168 [61; 275] 221 [−94; 537]
Inpatient care 2500 67 [8; 125] 2500 2500 51 [−6; 110] 125 [−51; 301]
Medical consultations 145 [127; 162] 47 [34; 59] 147 [127; 168] 136 [104; 169] 50 [35; 65] 30 [6; 53]
Osteoporosis treatment 54 [43; 66] 54 [43; 66] 61 [47; 74] 30 [12; 48] 61 [47; 74] 30 [12; 48]
Diagnostic tests (X-ray/
densitometry/CT scan)
31 [26; 35] 0 30 [26; 34] 34 [18; 50] 0 0
Nursing care 32 [24; 40] 0 31 [21; 40] 36 [20; 52] 0 0
Total direct medical costs 3818 [3603; 4046] 347 [210; 484] 3809 [3569–4072] 3851 [3397; 4304] 330 [192–450] 406 [−18; 849]
Direct non-medical costs
Long-term care 982 [606; 1357] 172 [−167; 510] 1008 [568; 14479] 887 [166; 1607] 219 [−214; 652] 0
Nursing home 1383 [939; 1828] 1114 [696; 1533] 1299 [804; 1794] 1691 [647; 2734] 970 [535; 1406] 1640 [487; 2792]
Home care 855 [477; 1232] 803 [431; 1175] 916 [467; 1364] 632 [−31; 1295] 850 [408; 1291] 632 [−31; 1295]
Technical aids 588 [395; 781] 0 599 [368; 830] 548[220; 876] 0 0
Transportation 74 [48; 101] 0 71 [43; 100] 86 [20; 153] 0 0
Buriala 149 [90; 208] 0 163 [94; 233] 94 [−12; 201] 0 0
Informal care 5391 [4429; 6352] 3549 [2718; 4379] 5628 [4524; 6732] 4523 [2519; 6525] 3870 [2889; 4851] 2375 [919; 3832]
Total direct non-medical
costs
9422 5638 9684 8461 5909 4647
[8339; 10,504] [4658; 6618] [8452; 10,935] [6162; 10,696] [4785; 7035] [2606; 6688]
Productivity loss 194 0 0 904 0 0
[−16; 405] [−77; 1885]
Total costs 13,434 5985 13,493 13,216 6239 5053
[12,290; 14,576] [4982; 7045] [12,187; 14,814] [10,782; 15,586] [5131; 7476] [5131; 7476]
The intervals in each cell represent the 95 % confidence interval
a Only the costs of burials due to excess mortality were computed
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million for the second year of care. Altogether, the cost of
osteoporotic hip fractures can be estimated at approximately
€216 million per year at current costs.
Mortality
Altogether, 50 (26.9 %) of the 186 patients included in this
study died within 2 years of suffering the hip fracture. Thirty-
eight of the deaths occurred in the first year (mortality rate
20.4 %) and 12 in the second (mortality rate of 8.1 %, 12/
148). Using Portuguese life tables [16], we estimated the ex-
pected yearly mortality for the general population, of similar
age and gender composition, to be approximately 8.6 %.
Thus, our data demonstrate that an excess of mortality is ob-
served in association with hip fracture within the first
12 months after the fracture, being nullified in the second year
and presumably thereafter.
On this basis, we estimate that a total of 2272 deaths will
have occurred in Portugal following the 11,124 hip fractures
observed in 2011, as opposed to the 962 expected in that
population. Therefore, we conclude that probably around
1310 excess deaths occur every year as a consequence of hip
fractures.
The survival functions were not significantly influenced by
either gender (p=0.47) or education (categorized in four
levels, p=0.98) or age (categorized into three age groups p=
0.15), according to the log-rank test.
Quality of life
The mean pre-fracture HrQoL score was 0.65 (95 % CI [0.63,
0.69]). Values for males and females were very similar to the
reference for the Portuguese population of similar age [9]
(0.68 vs 0.67 for men; 0.65 vs 0.56 for women).
One month after the fracture, the HrQoL decreased mark-
edly to −0.18 (95 % CI [−0.22, −0.15]). A two-sample paired
Student’s t-test clearly rejected the hypothesis of equal HrQoL
before and after the fracture (p<0.001). One year after the
fracture, patients partially recovered HrQoL, the average be-
ing, by then, 0.29 (95 % CI [0.22, 0.36]).
Figure 1 shows health utility measured using the EQ-5D
before, 1 month after and 1 year after the hip fracture. On
average, women report lower HrQoL scores than males, but
the differences observed did not reach statistical significance.
Factors influencing quality of life
We performed multivariate regression analysis to analyse
whether short and long-term relative losses and 1-year recov-
ery of HrQoL, as defined in Table 2 of the Supplementary
Material, are associated with specific individual characteris-
tics. Results are presented in Table 4. In all models, the dis-
turbances were found to be homoskedastic by the Breusch-
Pagan/Cook-Weisberg test, and no multicollinearity problems
were found.
None of the covariates included in the model demonstrated
to be relevant in explaining the short-term relative loss of
HrQoL. Regarding long-term impact, the data show that the
covariates ‘age’ and ‘level of education’ have a statistically
significant impact upon relative loss of HrQoL at 1 year after
fracture. Age is associated with higher long-term relative loss.
On the other hand, longer duration of formal education is
associated with a lower relative loss of HrQoL.
The covariates age (−0.008) and being transferred to
a long-term care facility after the fracture (−0.471) were
negatively associated with the 1-year recovery variable.
Females, those with more years of education and those
who received physiotherapy after fracture recovered, on
average, more HrQoL 1 year after the fracture than their
counterparts.
Discussion
The objective of this investigation was to estimate the total
annual cost of osteoporotic hip fractures to the Portuguese
society, the per-patient costs and the impact of these fractures
upon patients’ HrQoL and life expectancy. We estimated that
the total cost of the osteoporotic hip fractures in Portugal, in
2011, was nearly €216 million with a per-patient cost of €13,
434 in the first year and €5985 in the second year following
fracture. Direct non-medical costs represent over 70 % of the
overall expenditure. Indirect costs related with loss of produc-
tivity were marginal given the average age of the affected
population. Higher age is associated with higher per-patient
costs. This represents a very important burden upon the na-
tional health budget even if the absolute values are much low-
er than in northern European countries where both the inci-
dence of fracture and their individual cost are much higher
than in Portugal [5, 11, 17, 18].
Our results demonstrate that a hip fracture has a major
impact on the individuals’ HrQoL, which persists for at least
1 year. The EQ-5D scores were at baseline, in our sample,
similar to the reference values for the age- and gender-
matched Portuguese population. The average HrQoL at
1 month after fracture was rated at levels equivalent to ‘worse
than death’. At 1 year, there was considerable recovery of
HrQoL, but it still persisted significantly below baseline
levels. The impact of HrQoL at 1 year is increased with in-
creasing age and reduced in relation to higher levels of
education.
Hip fractures in Portugal are associated with significant
mortality: 26.9 % of the victims had died within 2 years after
fracture. This represents an excess of about 12 % in observed
versus expected mortality, which is observed almost exclu-
sively in the first year after fracture. Altogether, we estimate
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that hip fractures observed in Portugal during the year 2011
were responsible for an excess of over 1310 deaths. Excess
mortality attributable to fractures and its cost probably need to
be down-adjusted given that patients who sustain a hip frac-
ture are, on average, frailer than the general population.
However, as there is no solid basis to quantify this adjustment,
we decide to present absolute numbers and underline this po-
tential limitation. On the other hand, given that the excess
mortality occurs mostly on the first year, it will tend to reduce
other costs associated with care of the surviving patient with
fracture.
To the best of our knowledge, this is the first study to
collect individual-level data regarding the cost of osteoporotic
hip fractures in Portugal. The results confirm that hip fractures
represent a relevant socio-economic burden to the individual,
family, health services and society in Portugal.
Comparisons of results obtained with cost of illness studies
should be made with caution, as both the reality under evalu-
ation and the methodology employed can vary considerably.
The total societal cost of one hip fracture estimated by our
study is similar to that reported for most other developed
countries. For example, the per-patient fracture-related cost,
Table 4 Predictors of relative loss of HrQoL following hip fracture and its recovery
Short-term relative loss Long-term relative loss 1-year recovery (absolute values)
Β p value β p value β p value
Female 0.113 0.26 0.012 0.93 0.159 0.05*
Age −0.001 0.93 0.019 0.03* −0.008 0.05*
Married 0.101 0.40 −0.113 0.59 0.105 0.35
Level of education 0.001 0.98 −0.081 0.001* 0.024 0.04*
Living alone before 0.008 0.94 −0.127 0.54 −0.069 0.52
Nursing home before 0.097 0.57 −0.022 0.95 0.080 0.70
Physiotherapy – – −0.001 0.54 0.002 0.01*
Living alone after –– – −0.229 0.21 0.236 0.02*
Nursing home after – – 0.390 0.06 −0.120 0.24
Long-term care after – – 0.655 0.08 −0.477 0.01*
R2 0.02 0.17 0.25
β regression coefficient
*Statistically significant
Fig. 1 EQ-5D score before, one
month after and one year after
fracture, by gender, and the age
matched references for the
Portuguese population [9]
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per year, after a hip fracture was estimated at €16,379 in the
Netherlands in 2014 [18], €14,221 in Sweden, by 2006 [11],
and €13,205 in the USA in 2013 [17]. Reported costs in
China are considerably lower: € 3177 [10]. Discrepancies be-
tween these estimates seem to be essentially due to difference
in costs per unit of care, rather than consumption of resources.
It is quite possible that our total costs are underestimated by
the use of the national tariff for services provided in the
Portuguese NHS, which are commonly considered
underpriced. On the other hand, we have considered costs that
are frequently ignored by studies in this area, such as the cost
of burial and of informal care. In support of this approach, we
would argue that death is associated with a direct cost of its
own which should be appropriately considered as a non-
medical direct cost. Similarly, the care provided by family
and friends would have to be provided by someone in their
absence and therefore represents a societal cost, even if it is
endured by family and/or friends. We have only accounted for
the costs of excessive number of deaths probably due to hip
fractures (12 %) and attributed to informal care the cost equiv-
alent to our current national minimum wage, €505/month.
The percentage of patients undergoing treatment for osteo-
porosis with specific agents (16.7 %) or with calcium plus
vitamin D (29.6 %) after hip fracture is worryingly small.
These percentages are nevertheless in line with international
results [7, 10, 17, 19] and emphasize the urgent need for strat-
egies to improve the management of osteoporosis after
fracture.
We identified that 17.8 % of women and 20 % of men
living in the community at the time of fracture entered a
long-term care facility and that 18.5 % of women and 25 %
of men were admitted to a nursing home during the first year
after fracture. These values are in agreement with previous
studies and demonstrate that loss of independence after hip
fracture is a critical problem for these patients and for society
[16, 20, 21].
The results presented here support previous research dem-
onstrating that hip fractures are associated with a substantial
decrement in HrQoL [11, 22–24]. In a systematic review, hip
fractures were associated with a HrQoL decrement of approx-
imately 50 % shortly after fracture and 20 % 4 months after
fracture [23]. In our study, HrQoL values are close to the
estimates found in others studies, with the exception of
HrQoL 1 month after the event, which is remarkably lower
in our case. This difference may be related to the exact time of
evaluation, as HrQoL changes rapidly under these circum-
stances. Cultural issues may also play a role [22].
Our results need to be viewed in the light of several positive
aspects and also limitations. Among the positive aspects, we
underline the representative nature of our sample, derived not
only from its size but also from the random selection strategy
ensuring a valuable similarity between our sample and the
overall population in terms of age, gender and geographic
provenience. We have adopted statistical methodologies of
analysis that are well rooted in the literature of COI studies.
Our limitations include the retrospective collection of data,
which may have some negative impact on the precision of
the results, although several authors and consensus groups
defend that personal health information can be collected with
reasonable precision if specific and pre-defined questions are
employed [25, 26]. We have carefully respected the ten main
recommendations published by Matt et al. [27] to ensure a
good collection of data in retrospective studies.
Baseline HrQoL could have been especially open to this
problem as patients might perceive their baseline HrQoL to be
better than it actually was, which could lead to an overestima-
tion of the loss of HrQoL due to the fracture. However, the
HrQoL scores described by our participants before fracture
were very similar to the reference for the Portuguese popula-
tion [9]. Our cost estimates may be underestimated for the use
of national tariffs instead of market prices.
We opted to include all randomized patients even when the
information could only be provided by a primary caregiver.
Although this may be seen as a limitation, there is evidence
that proxies can provide reliable information regarding EQ-
5D scores [28, 29] and resource utilization and costs of hip
fractures [30–32], when patients are not able or available to do
so. We also verified in a regression model if the type of re-
spondent (caregiver/patient) influences the costs and quality
of life, and this variable does not influence either costs or
quality of life. Data are not shown.
Conclusion
The results of this study demonstrate that osteoporotic hip
fractures represent an important cause of health resource con-
sumption and overall societal cost in Portugal, despite its rel-
atively low incidence in our country. Hip fractures have a
marked negative effect on HrQoL, which persists for at least
1 year, and a significant impact onmortality. It is expected that
the costs and societal impact of osteoporotic hip fractures will
rise with the projected increase of life expectancy and the
feminization of the elderly population.
Further research is needed to evaluate the cost-
effectiveness of different strategies to prevent osteoporotic
fractures and to limit their impact on the HrQoL and life ex-
pectancy of its victims.
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